Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioMarin Pharmaceutical (BMRN)
NASDAQ:BMRN
RESEARCH TOOLSreports
BioMarin Pharmaceutical (BMRN) Blogger Opinions & Sentiment
1,826 Followers
Blogger Sentiment
Sector Average
Bullish
Blogger Article Distribution
33% SeekingAlpha
33% InvestorPlace
11% MotleyFool
23% Others
The distribution of articles among the main online Financial Blogging platforms.
Top Blogger Bearish Predictions
Not enough top blogger opinions at this time
Please return soon. This page is being updated.
Recent negative articles by top bloggers.
Top Blogger Bullish Predictions
The 3 Best Biotech Stocks to Buy in May 2024
Buy These 4 Low-Beta Stocks to Counter Market Volatility
If You Can Only Buy One Biotech Stock in January, It Better Be One of These 3 Names
Recent positive articles by top bloggers.
Financial Blogger Predictions
Blogger Performance
Any
Blogger Sentiment
Any
Zacks Equity Research
Bullish
Buy These 4 Low-Beta Stocks to Counter Market Volatility
InvestorPlace
Bullish
If You Can Only Buy One Biotech Stock in January, It Better Be One of These 3 Names
TipRanks Contributor
Bullish
Under the Microscope: 3 Biotech Stocks Pioneering Tomorrow’s Cures
FAQ
What do Seeking Alpha bloggers think of BMRN?
Seeking Alpha’s Denis Buivolov has a Bullish Sentiment.
What do Motley Fool contributors think of BMRN?
Currently there's no blogger sentiment for BMRN.
What Is BMRN’s Blogger Sentiment?
BMRN’s Blogger Sentiment is Bullish.
What was the most recent blogger prediction for BMRN?
The most recent blogger prediction for BMRN was made by Denis Buivolov , who was Bullish on the stock.
How can I follow the stock ratings of top Top Financial Bloggers?
Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.